XENE
Xenon Pharmaceuticals Inc. · Healthcare
Director Gary Patou sold $201K of Xenon Pharmaceuticals Inc.
Sold$200,947
$41.09Price
4,891Shares
−15%Stake
What XENE did after the filing
- The stock from Fri, Nov 22 close, $41.15
- −3.9%
- S&P 500, same days
- −0.7%
Measured over 30 trading days, to the Jan 8 close.
Traded Fri, Nov 22. Filed Fri, Nov 22, 2:48 PM ET, during the session. Returns use the Nov 22 close and the Jan 8 close. Not investment advice.